Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
Journal of the Neurological Sciences, ISSN: 0022-510X, Vol: 376, Page: 242-254
2017
- 199Citations
- 307Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations199
- Citation Indexes199
- 199
- CrossRef188
- Captures307
- Readers307
- 307
- Mentions1
- News Mentions1
- 1
Most Recent News
Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis.
J Neurol Sci. 2017 May 15;376:242-254. Epub 2017 Mar 22 Authors: Bagyinszky E, Giau VV, Shim K, Suk K, An SS, Kim S PubMed: 28431620 Submit Comment
Review Description
Alzheimer's disease (AD) is a complex disorder and the most common form of neurodegenerative dementia. Several genetic, environmental, and physiological factors, including inflammations and metabolic influences, are involved in the progression of AD. Inflammations are composed of complicated networks of many chemokines and cytokines with diverse cells. Inflammatory molecules are needed for the protection against pathogens, and maintaining their balances is important for normal physiological function. Recent studies demonstrated that inflammation may be involved in neurodegenerative dementia. Cellular immune components, such as microglia or astrocytes, mediate the release of inflammatory molecules, including tumor necrosis factor, growth factors, adhesion molecules, or chemokines. Over- and underexpression of pro- and anti-inflammatory molecules, respectively, may result in neuroinflammation and thus disease initiation and progression. In addition, levels of several inflammatory factors were reported to be altered in the brain or bodily fluids of patients with AD, reflecting their neuropathological changes. Therefore, simultaneous detection of several inflammatory molecules in the early or pre-symptomatic stage may improve the early diagnosis of AD. Further studies are needed to determine, how induction or inhibition of inflammatory factors could be used for AD therapies. This review summarizes the role or possible role of immune cells and inflammatory molecules in disease progression or prevention.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0022510X17302009; http://dx.doi.org/10.1016/j.jns.2017.03.031; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85016398959&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/28431620; https://linkinghub.elsevier.com/retrieve/pii/S0022510X17302009; https://dx.doi.org/10.1016/j.jns.2017.03.031
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know